These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12230858)

  • 1. Who are the guardians guarding?
    Trachtman H
    Am J Bioeth; 2002; 2(3):46-8. PubMed ID: 12230858
    [No Abstract]   [Full Text] [Related]  

  • 2. The Cipro patent and bioterrorism.
    Kaye KS; Kaye D
    Am J Bioeth; 2002; 2(3):41-2. PubMed ID: 12230854
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract]   [Full Text] [Related]  

  • 4. Compulsory licensure: the case of Cipro and beyond.
    Chakrabarty AM
    Am J Bioeth; 2002; 2(3):40. PubMed ID: 12230853
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond government intervention: drug companies and bioethics.
    Dresser R
    Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855
    [No Abstract]   [Full Text] [Related]  

  • 6. Not taking, just borrowing: government use of patented drugs.
    Ossorio PN
    Am J Bioeth; 2002; 2(3):51-2. PubMed ID: 12230861
    [No Abstract]   [Full Text] [Related]  

  • 7. It is not unethical, though it is often unwise, to override patents.
    Leventer H
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract]   [Full Text] [Related]  

  • 8. Patents: the public interest versus the private privilege.
    Parsi KP; Egan EA
    Am J Bioeth; 2002; 2(3):45-6. PubMed ID: 12230857
    [No Abstract]   [Full Text] [Related]  

  • 9. Life, death, and monopoly rights in a democratic society.
    Smith SJ
    Am J Bioeth; 2002; 2(3):43-4. PubMed ID: 12230856
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioterrorism, public health, and international law.
    Fidler DP
    Chic J Int Law; 2002; 3(1):7-26. PubMed ID: 15709296
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent immorality?
    Bloche MG; Jungman ER
    Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
    [No Abstract]   [Full Text] [Related]  

  • 12. The burgeoning science of genetics and the impact on public policy.
    Hatch OG
    J Biolaw Bus; 2004; 7(4):3-6. PubMed ID: 15675088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIPS: generic irony.
    Howarth GR
    Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to commentaries : Resnik, D. B. and K. A. DeVille. 2002. "Bioterrorism and patient rights: 'compulsory licensure' and the case of Cipro." The American Journal of Bioethics 2(3): 29-39.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(4):W1. PubMed ID: 12816075
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 16. Promega changes tack in battle over patent.
    Knight J
    Nature; 2003 Nov; 426(6965):373. PubMed ID: 14647346
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioterrorism, public health, and civil liberties.
    Annas GJ
    N Engl J Med; 2002 Apr; 346(17):1337-42. PubMed ID: 11973377
    [No Abstract]   [Full Text] [Related]  

  • 18. US policy may encourage counterfeit drugs.
    Bouchie A
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract]   [Full Text] [Related]  

  • 19. Washington Insider: Congressional impasse on human cloning.
    Doerflinger RM
    Natl Cathol Bioeth Q; 2004; 4(1):19-25. PubMed ID: 15192847
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomedical patents and the public's health: is there a role for eminent domain?
    Kesselheim AS; Avorn J
    JAMA; 2006 Jan; 295(4):434-7. PubMed ID: 16434634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.